The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Kidney Int
; 99(4): 986-998, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33166580
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glomerulonephritis, Membranous
/
Tacrolimus
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Humans
Language:
En
Journal:
Kidney Int
Year:
2021
Document type:
Article
Affiliation country:
España